Wednesday, Jun 18, 2025 · SEC filings
What the smart money revealed on Jun 18
635 insider filings came in. We hid 138 planned (10b5-1) sellers and 344 people whose filings were routine, like grants and tax withholding.
5 insiders at Nuvation Bio (NUVB) bought $1.11M of stock
Roles: CEO, CFO, Chief People Officer, Chief Regulatory Officer, Chief Commercial Officer. Several insiders buying in the same few days is rare.
Blue Acquisition (BACC) CEO Ketan Seth bought $3.91M
391,000 shares on the open market. Not a grant or an option exercise.
Ardelyx (ARDX) Director David Mott bought $726K
200,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 4 checked quarters beat the typical stock 6 months later.
G III Apparel Group (GIII) Executive Vice President Jeffrey Goldfarb bought $492K
23,076 shares on the open market. Not a grant or an option exercise.
WillScot (WSC) Director Dominick Zarcone bought $262K
10,000 shares on the open market. Not a grant or an option exercise.
Rocket Lab (RKLB) Director Matthew Ocko sold $26.6M
Not marked as a planned 10b5-1 sale. Sold 21% of the shares they held directly. Still holds 3.75M shares.
Sprinklr (CXM) Director Ragy Thomas sold $24.1M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 974,286 shares directly.
BeOne Medicines (ONC) CEO John Oyler sold $1.35M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 34 more real buys
Show 84 more real sales
13F season
Holdings as of Mar 31, 2025 were due May 15
92 funds have filed. 80 filed for the quarter before.
Biggest real insider buys, Jun 12–18
Open-market buys by officers and directors, filed in the 7 days up to Jun 18.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.